A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast Cancer
Titel:
A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast Cancer
Auteur:
File, Danielle M. Abdou, Yara Force, Jeremy Moore, Dominic T. Anders, Carey K. Reeder-Hayes, Katherine Carey, Lisa A. Muss, Hyman B. Perou, Charles M. Marcom, P. Kelly Dees, E. Claire